Earnings History Data for ImmunoPrecise Antibodies Ltd. (IPA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-03-2024 | PM | IPA | ImmunoPrecise Antibodies Ltd. | 41.08 | -0.08 | -0.08 | -0.14 | ImmunoPrecise GAAP EPS of -C$0.11, revenue of C$6.2M [3/14/2024 8:09 AM] |
1.55 | -0.08 (-4.91%) |
1.62 | -0.01 (-0.61%) |
0.94 - 4.22 | 459,618 | 3,060,000 | 8,637 | ||
| 14-12-2023 | PM | IPA | ImmunoPrecise Antibodies | 29.00 | -0.07 | -0.09 | 0.00 | ImmunoPrecise GAAP EPS of -$0.10, revenue of $6.2M [12/14/2023 12:49 PM] |
1.43 | 0.23 (19.15%) |
1.20 | 0.0 (0.00%) |
0.94 - 5.90 | 217,584 | 280,000 | 19,140 | ||
| 14-09-2023 | PM | IPA | ImmunoPrecise Antibodies Ltd. | 49.60 | -0.11 | -0.17 | -0.30 | 2.00 | -0.02 (-0.99%) |
2.21 | 0.19 (9.41%) |
1.71 - 5.90 | 152,986 | 40,000 | 20,691 | |||
|
|
||||||||||||||||||
| 10-07-2023 | PM | 8:00 AM ET (Jul 7) |
IPA | ImmunoPrecise Antibodies Ltd. | 75.89 | -0.15 | -0.12 | -0.17 | ImmunoPrecise reports FY results [7/7/2023 8:25 AM] |
2.95 | -0.08 (-2.64%) |
3.18 | 0.15 (4.95%) |
2.35 - 6.50 | 76,796 | 20,000 | 8,550 | |
| 16-03-2023 | PM | 8:00 AM ET (Mar 16) |
IPA | ImmunoPrecise Antibodies Ltd. | 99.24 | -0.14 | -0.12 | -0.16 | ImmunoPrecise Antibodies reports Q3 results [3/16/2023 8:07 AM] |
3.40 | -0.35 (-9.33%) |
0.0 | 0.0 (0.00%) |
3.25 - 6.50 | 91,905 | 30,000 | 0 | |
| 15-12-2022 | PM | 8:00 AM ET (Dec 15) |
IPA | ImmunoPrecise Antibodies | 138.00 | -0.23 | -0.14 | 0.00 | ImmunoPrecise Antibodies GAAP EPS of -C$0.30, revenue of C$5.18M [12/15/2022 8:11 AM] |
4.89 | -0.47 (-8.68%) |
5.60 | 0.24 (4.48%) |
3.51 - 6.79 | 66,165 | 20,000 | 615 | |
| 14-09-2022 | PM | Before the open (Sep 14) |
IPA | ImmunoPrecise Antibodies Ltd. | 93.92 | -0.30 | 0.00 | -0.14 | ImmunoPrecise Antibodies reports FQ1 results [9/14/2022 8:43 AM] |
4.88 | -0.50 (-9.39%) |
0.0 | 0.0 (0.00%) |
3.51 - 7.05 | 24,464 | 10,000 | 0 | |
|
||||||||||||||||||
| 29-07-2022 | PM | Before the open (Jul 29) |
IPA | ImmunoPrecise Antibodies Ltd. | 93.92 | -0.17 | 0.00 | -0.23 | ImmunoPrecise Antibodies reports FY results [7/29/2022 8:52 AM] |
4.23 | -0.32 (-7.03%) |
4.80 | 0.25 (5.49%) |
3.51 - 8.70 | 16,499 | 20,000 | 806 | |
| 16-03-2022 | PM | Before the open (Mar 16) |
IPA | ImmunoPrecise Antibodies Ltd. | 73.83 | -0.16 | 0.00 | 0.00 | ImmunoPrecise Antibodies reports Q3 results [3/16/2022 8:06 AM] |
3.92 | -0.03 (-0.76%) |
3.95 | 0.0 (0.00%) |
3.51 - 16.47 | 66,886 | 36,886 | 0 | |